Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled Trial
Clinical trial NCT01255215 · COMPLETED
Trial details
- NCT number
- NCT01255215
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-07-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.